학술논문

Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience
Document Type
Article
Source
In: Frontiers in Oncology. (Frontiers in Oncology, 2023, 13)
Subject
Language
English
ISSN
2234943X